The global T‑Cell Therapy Market is entering a new era of expansion, driven by revolutionary advances in immuno‑engineering and an urgent need for more effective cancer treatments. According to Roots Analysis, the market—which was valued at under a billion dollars in 2024—is projected to grow at a robust compound annual growth rate (CAGR) through 2035. This growth is underpinned by...